🔎 Trials Near Me

홈 › 자궁내막암 › 텍사스 › Houston

TX Houston의 자궁내막암 임상 시험

자궁내막암 관련 연구 68개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

피험자 모집 중2상
  • Lyndon Baines Johnson General Hospital, Houston
  • UT MD Anderson Cancer Center, Houston
전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06270706

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

피험자 모집 중2상
  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06760819

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

피험자 모집 중2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07189871

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

피험자 모집 중관찰 연구
  • Total Women's Care of the Heights, Houston
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05051722

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

피험자 모집 중1상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT03564340

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

피험자 모집 중2상
  • M.D. Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 9. 24. 업데이트됨 · NCT05640999

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

피험자 모집 중2상
  • Research Site, Houston
18세 ~ 130세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

피험자 모집 중1/2상
  • MD Anderson, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

피험자 모집 중1/2상
  • University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07262619

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

피험자 모집 중1상
  • Oncology Consultants, P.A., Houston
  • University of Texas M.D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

피험자 모집 중3상
  • Houston Methodist Hospital ( Site 6057), Houston
18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

피험자 모집 중관찰 연구
  • MD Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 9. 16. 업데이트됨 · NCT06409052

Sentinel Node Biopsy in Endometrial Cancer

피험자 모집 중3상
  • Houston Methodist Hospital, Houston
18세 이상 · 여성 · 2026. 9. 15. 업데이트됨 · NCT04073706

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

피험자 모집 중1/2상
  • Research Site, Houston
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

피험자 모집 중1상
  • Oncology Consultants, Houston
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas - MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06400472

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT07755436

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

피험자 모집 중3상
  • Research Site, Houston
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • M. D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07216105

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

피험자 모집 중1/2상
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

피험자 모집 중1상
  • MD Anderson, Houston
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

피험자 모집 중1/2상
  • Research Site, Houston
18세 ~ 130세 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT05797168

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT07306559

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

피험자 모집 중2상
  • University of Texas, MD Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 8. 21. 업데이트됨 · NCT05548296

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

피험자 모집 중1상
  • Normunity Investigational Site, Houston
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

피험자 모집 중관찰 연구
  • The Harris Health System (LBJ), Houston
  • MD Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 8. 12. 업데이트됨 · NCT07382583

A Study of PHST001 in Advanced Solid Tumors

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas, MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

피험자 모집 중관찰 연구
  • Houston Methodist Cancer Center (Data Collection Only), Houston
18세 이상 · 여성 · 2026. 8. 7. 업데이트됨 · NCT04291612

A Study of DM002 in Patients With Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas, MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06751329

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

피험자 모집 중1상
  • NEXT - Oncology - Houston, Houston
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07444814

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

피험자 모집 중3상
  • Research Site, Houston
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • Investigative Site #129, Houston
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07524322

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

피험자 모집 중1상
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT05092373

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

피험자 모집 중2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT06695845

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT07458347

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

피험자 모집 중1/2상
  • MD Anderson, Houston
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT06993844

A Study of LY4175408 in Participants With Advanced Cancer

피험자 모집 중1상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07046923

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

피험자 모집 중1상
  • MD Anderson, Houston
  • NEXT Texas LLC - Houston, Houston
18세 이상 · 모든 성별 · 2026. 6. 18. 업데이트됨 · NCT07503808

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

피험자 모집 중1상
  • M D Anderson Cancer Center, Houston
18세 이상 · 여성 · 2026. 6. 8. 업데이트됨 · NCT05819892

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

피험자 모집 중1상
  • The University of Texas MD Anderson Cancer Center, Houston
16세 이상 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT07197554

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

피험자 모집 중2상
  • The University of Texas MD Anderson Cancer Center, Gynecologic Oncology Center, Houston
18세 이상 · 여성 · 2026. 6. 2. 업데이트됨 · NCT06730347

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

피험자 모집 중1상
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 6. 1. 업데이트됨 · NCT05039801

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06239194

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06395519

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

피험자 모집 중1상
  • M D Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2026. 3. 11. 업데이트됨 · NCT03968406

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

피험자 모집 중1/2상
  • The University of Texas MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT06943521

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

피험자 모집 중1/2상
  • M.D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 11. 4. 업데이트됨 · NCT05902988

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

피험자 모집 중2상
  • MD Anderson Cancer Center - U of Texas, Houston
18세 ~ 70세 · 여성 · 2025. 10. 30. 업데이트됨 · NCT06481592

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구
  • Massive Bio SYNERGY-AI site, Houston
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

피험자 모집 중
  • Baylor College of Medicine- McNair Campus, Houston
  • Baylor College of Medicine, Houston
  • Ben Taub General Hospital, Houston
  • 외 1개
18세 ~ 90세 · 여성 · 2025. 10. 15. 업데이트됨 · NCT04586959

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

피험자 모집 중1/2상
  • MD Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT05941507

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

피험자 모집 중1상
  • The University of Texas M.D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 3. 7. 업데이트됨 · NCT04196257

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

피험자 모집 중1/2상
  • Oncology Consultants, P.A., Houston
  • The University of Texas M. D. Anderson Cancer Center, Houston
18세 이상 · 모든 성별 · 2025. 2. 13. 업데이트됨 · NCT05669430

Comprehensive Outcomes for After Cancer Health

피험자 모집 중건강한 지원자 환영
  • The University of Texas MD Anderson Cancer Center, Houston
  • UT Health Houston, Houston
18세 이상 · 모든 성별 · 2024. 12. 11. 업데이트됨 · NCT05349227

HPV Vaccine, Imiquimod, and Metformin Combination Trial

피험자 모집 중2상
  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
18세 ~ 64세 · 여성 · 2024. 11. 13. 업데이트됨 · NCT06686043

다른 도시의 자궁내막암 시험

Houston의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.